Pharma & Biotech - Page 8

CMI Media Group, a precision healthcare communications company and subsidiary of WPP (NYSE: WPP), has formally launched a new specialty communications business unit. The Philadelphia-based organisation has long focused on developing proprietary

Fresenius, the German drugmaker, has received a warning letter from the US Food and Drug Administration targeting its Fenwal blood-products facility in Puerto Rico. The FDA issued the warning following an inspection

Replimune (REPL) secured a landmark accelerated approval for its cancer therapy Tudriqev last month, following a pivotal intervention from senior FDA leadership. Two votes of confidence from officials at the FDA’s Office

Amgen (AMGN) has unveiled compelling new data showing its cholesterol-lowering drug Repatha significantly reduces the risk of death in high-risk cardiovascular patients. The findings, announced on 31 August 2026, come from a

The pharmaceutical distribution industry is closely watching the development of a national licensure standard that could reshape compliance requirements for wholesalers and third-party logistics providers. Kala Shankle, JD, Vice President of Regulatory

Novartis has announced plans to cut approximately 130 jobs in Switzerland as it restructures laboratory and production activities at its Kleinbasel site in Basel. The Swiss pharmaceutical giant confirmed it will transfer

The pharmaceutical industry has entered a planning and preparation phase following the FDA’s publication of its final rule on 12-digit National Drug Codes. Liberty Dewey, manager of DSCSA at Cardinal Health, describes

The US health research agency ARPA-H has awarded up to $125 million across five teams to build automated systems capable of producing personalised RNA medicines in under a week. The funding forms

Independent Pharmacy Cooperative has completed its acquisition of USave Pharmacy Group, with the deal taking effect on September 1 of this year. The two purchasing organisations have worked in close collaboration for

Pharmaceutical advertising during NFL regular season games proved dramatically more effective than standard broadcast placements during the 2025-26 season, according to TV measurement firm EDO. Pharma ads airing during NFL regular season